kynurenic acid has been researched along with Brain Damage, Chronic in 1 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leib, SL | 1 |
| Kim, YS | 1 |
| Ferriero, DM | 1 |
| Täuber, MG | 1 |
1 other study available for kynurenic acid and Brain Damage, Chronic
| Article | Year |
|---|---|
Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis.
Topics: Animals; Animals, Newborn; Brain; Brain Damage, Chronic; Cerebral Cortex; Cerebrospinal Fluid; Denta | 1996 |